Spotlight -

Downstream Processing|

Upstream Processing

Christopher Gibson

Christopher Gibson is distinguished scientist, Merck.

Articles by Christopher Gibson

PAULISTA - STOCK.ADOBE.COM

Enabling the Virtual Human Through Physiologically-based Pharmacokinetic Modeling

ByHeidi J. Einolf ,Stephen D. Hall,Tracy Williams,Aarti Patel,Christopher Gibson,Nancy G.B. Agrawal,Jens Sydor

March 16th 2021

Basic principles of physiologically-based pharmacokinetic (PBPK) modeling and its impact in streamlining the drug development process are reviewed.

Latest Updated Articles

Enabling the Virtual Human Through Physiologically-based Pharmacokinetic Modeling
Published: March 16th 2021 | Updated:

Trending on BioPharm International

Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care

Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms

© 2025 MJH Life Sciences^®

All rights reserved.